SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905718-19-000433
Filing Date
2019-05-13
Accepted
2019-05-13 16:00:46
Documents
2
Group Members
NEWTYN PARTNERS, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A merrimack_13gam1may32019.htm SC 13G/A 60461
2 EX-1 merrimack_13ga1may32019exa.htm EX-1 6578
  Complete submission text file 0000905718-19-000433.txt   68606
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Subject) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86778 | Film No.: 19818322
SIC: 2834 Pharmaceutical Preparations

Mailing Address 405 PARK AVENUE SUITE 1104 NEW YORK NY 10022-9409
Business Address 405 PARK AVENUE SUITE 1104 NEW YORK NY 10022-9409 212-446-2460
Newtyn Management, LLC (Filed by) CIK: 0001569241 (see all company filings)

IRS No.: 453017573 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A